66 related articles for article (PubMed ID: 38674157)
1. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract][Full Text] [Related]
2. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
3. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
Busch M; Papior D; Stephan H; Dünker N
Oncol Rep; 2018 Jan; 39(1):160-172. PubMed ID: 29192327
[TBL] [Abstract][Full Text] [Related]
4. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
5. miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress.
Kong M; Han Y; Zhao Y; Zhang H
Med Sci Monit; 2020 Jul; 26():e923817. PubMed ID: 32641679
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.
Dong R; Wang T; Dong W; Zhu H; Liu Q; Liang H; Chen X; Zhang B; Zhang X
Biomed Pharmacother; 2024 Apr; 173():116366. PubMed ID: 38458013
[TBL] [Abstract][Full Text] [Related]
8. Role of c-Src in Carcinogenesis and Drug Resistance.
Raji L; Tetteh A; Amin ARMR
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201459
[TBL] [Abstract][Full Text] [Related]
9. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
Bahar ME; Kim HJ; Kim DR
Signal Transduct Target Ther; 2023 Dec; 8(1):455. PubMed ID: 38105263
[TBL] [Abstract][Full Text] [Related]
10. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A; Foo ASC; Lam HY; Yap KCH; Jacot W; Jones RH; Eng H; Nair MG; Makvandi P; Geoerger B; Kulke MH; Baird RD; Prabhu JS; Carbone D; Pecoraro C; Teh DBL; Sethi G; Cavalieri V; Lin KH; Javidi-Sharifi NR; Toska E; Davids MS; Brown JR; Diana P; Stebbing J; Fruman DA; Kumar AP
Mol Cancer; 2023 Aug; 22(1):138. PubMed ID: 37596643
[TBL] [Abstract][Full Text] [Related]
11. Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway.
Peng C; Zhang C; Yu W; Li L; Zhang Z; Liu T; Zhang Y; Fan G; Huangfu H
Curr Cancer Drug Targets; 2023; 23(6):471-481. PubMed ID: 36654463
[TBL] [Abstract][Full Text] [Related]
12. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D; Doege A; Alefeld E; Haase A; Beier M; Kiefer T; Biewald E; Metz K; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293469
[TBL] [Abstract][Full Text] [Related]
13. The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity.
Najafi F; Kelaye SK; Kazemi B; Foruzandeh Z; Allahverdizadeh F; Vakili S; Rad KK; Derakhshani M; Solali S; Alivand MR
Pathol Res Pract; 2022 Nov; 239():154130. PubMed ID: 36201929
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
